Q3 2018

Filed Nov 14, 2018 · 10-Q · 45 days after period end · 0001121781-18-000063

Q3 2018 · 10-Q

Revenue

$2.00K

−93.9% vs Q3 2017

Net Income

-$746.00K

N/M vs Q3 2017

EPS Diluted

-$1.60

N/M vs Q3 2017

Gross Profit$2,000N/M

Operating Income

Same quarter

Metric	Q3 2018	Q3 2017	Q3 2016	Q3 2015
Revenue	$2.00K	$33.00K	$95.00K	$8.00K
Net Income	-$746.00K	-$2.37M	-$211.00K	-$2.19M
EPS Diluted	-$1.60	-$0.35	-$1.36	-$1.75

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR